Functionalized Positive Nanoparticles Reduce Mucin Swelling and Dispersion

Abstract

Multi-functionalized nanoparticles (NPs) have been extensively investigated for their potential in household and commercial products, and biomedical applications. Previous reports have confirmed the cellular nanotoxicity and adverse inflammatory effects on pulmonary systems induced by NPs. However, possible health hazards resulting from mucus rheological disturbances induced by NPs are underexplored. Accumulation of viscous, poorly dispersed, and less transportable mucus leading to improper mucus rheology and dysfunctional mucociliary clearance are typically found to associate with many respiratory diseases such as asthma, cystic fibrosis (CF), and COPD (Chronic Obstructive Pulmonary Disease). Whether functionalized NPs can alter mucus rheology and its operational mechanisms have not been resolved. Herein, we report that positively charged functionalized NPs can hinder mucin gel hydration and effectively induce mucin aggregation. The positively charged NPs can significantly reduce the rate of mucin matrix swelling by a maximum of 7.5 folds. These NPs significantly increase the size of aggregated mucin by approximately 30 times within 24 hrs. EGTA chelation of indigenous mucin crosslinkers (Ca2+ ions) was unable to effectively disperse NP-induced aggregated mucins. Our results have demonstrated that positively charged functionalized NPs can impede mucin gel swelling by crosslinking the matrix. This report also highlights the unexpected health risk of NP-induced change in mucus rheological properties resulting in possible mucociliary transport impairment on epithelial mucosa and related health problems. In addition, our data can serve as a prospective guideline for designing nanocarriers for airway drug delivery applications.

Metabolomic Evaluation of Neutrophilic Airway Inflammation in Cystic Fibrosis

“…34 Interestingly, genetic studies suggest that activity of the methionine salvage pathway, which plays a critical role in polyamine synthesis, is increased in patients with CF who have more severe lung disease. 35 Th ese fi ndings suggest that polyamines may be both a biomarker and a therapeutic target for CF airways disease and COPD.…”

Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?

“…In every case, nanoparticle interference with the barrier properties of cervicovaginal fluids should be limited as it may constitute an important defense against different pathogens, namely HIV‐1 or HSV‐2 54,55. In the case where mucoadhesive interactions are established, rearrangements of the mucus structure are possible and have been demonstrated for different polymers56 and nanoparticles,57 particularly when positively charged, thus recommending caution when mucoadhesion is required.…”

Early detection of colonic dysplasia by magnetic resonance molecular imaging with a contrast agent raised against the colon cancer marker MUC5AC

“…This could be explained by the properties of secreted mucins that have the ability to form gels with other molecules by hydrogen bonding or by hydrophilic and hydrophobic interactions . MUC5AC may form a gel by crosslinking with USPIO–60C, as has been shown with other nanoparticles , thereby limiting the diffusion of the USPIOs within the mucus. Different approaches have described interference of the gastrointestinal mucus with topical nanoparticle administration .…”